The purpose of this study is to determine whether intensive lipid lowering and Omega-3 fatty acid are effective in the treatment of coronary atherosclerotic plaque.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
Atorvastatin 40mg qd plus Omega3-fatty acid 2.0mg qd
atorvastatin 10mg qd plus Omega3-fatty acid 2.0mg qd
atorvastatin 40mg qd
Cardiac and Vascular Center; Samsung Medical Center
Seoul, South Korea
RECRUITINGPlaque stabilization using serial virtual histology intravascular ultrasound analysis
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
atorvastatin 10mg qd